Dicloxacillin
- Generic Name
- Dicloxacillin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H17Cl2N3O5S
- CAS Number
- 3116-76-5
- Unique Ingredient Identifier
- COF19H7WBK
- Background
One of the penicillins which is resistant to penicillinase.
- Indication
Used to treat infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug.
- Associated Conditions
- Infections caused by penicillinase-producing staphylococci
- Associated Therapies
- -
Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis
Phase 4
Not yet recruiting
- Conditions
- Interventions
- Drug: Ciprofloxacin TabletsDrug: CefaclorDrug: Ciprofloxacin InjectionDrug: Clindamycin Oral CapsuleDrug: Dicloxacillin Oral CapsuleDrug: Clindamycin InjectionDrug: Fusidic Acid Only Product in Oral Dose FormDrug: DicloxacillinDrug: Fusidic Acid Only Product in Parenteral Dose FormDrug: Levofloxacin Oral TabletDrug: Levofloxacin InjectionDrug: Linezolid Oral TabletDrug: Linezolid Injectable ProductDrug: Moxifloxacin tabletDrug: Moxifloxacin Injectable ProductDrug: Rifampicin Only Product in Oral Dose FormDrug: Rifampicin Only Product in Parenteral Dose FormDrug: Sulfamethoxazole / Trimethoprim Oral Tablet [Bactrim]Drug: Sulfamethoxazole / Trimethoprim Injectable ProductDrug: Tedizolid Oral TabletDrug: Tedizolid InjectionDrug: Amoxicillin CapsulesDrug: Cefaclor CapsulesDrug: Amoxicillin
- First Posted Date
- 2022-06-01
- Last Posted Date
- 2022-06-01
- Lead Sponsor
- Fundacion Clinic per a la Recerca Biomédica
- Target Recruit Count
- 360
- Registration Number
- NCT05398679
- Locations
- 🇪🇸
Hospital Clinic i Provincial de Barcelona, Barcelona, Spain
The Effect of Dicloxacillin on Oral Absorption of Drugs
- First Posted Date
- 2021-10-11
- Last Posted Date
- 2022-07-21
- Lead Sponsor
- University of Southern Denmark
- Target Recruit Count
- 12
- Registration Number
- NCT05073627
- Locations
- 🇩🇰
University of Southern Denmark, Odense, Region Of Southern Denmark, Denmark
Dicloxacillin: Clinical Relevance of Drug-drug Interactions by Induction of Drug Metabolism.
- First Posted Date
- 2016-12-06
- Last Posted Date
- 2018-08-23
- Lead Sponsor
- Per Damkier
- Target Recruit Count
- 12
- Registration Number
- NCT02983890
- Locations
- 🇩🇰
Klinisk Biokemisk Farmakologi syddansk universitet, Odense, Funen, Denmark
Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria
Phase 3
Completed
- Conditions
- First Posted Date
- 2002-05-15
- Last Posted Date
- 2009-09-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 739
- Registration Number
- NCT00037050
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath